chrisvoncsefalvay/vaers-outcomes huggingface dataset:
febrile sz on 24MAR96;duration 4mins;also found to have OM on exam 25MAR96;
Pain & swelling at site of injection. Rash developed on forearm below inj site & down to elbow 2 days later persisted.
presumably on antibiotic after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (presumably on antibiotic after the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (presumably on antibiotic after the vaccine). At the time of the report, VACCINATION COMPLICATION (presumably on antibiotic after the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported. No treatment information was reported.   Reporter did not allow further contact
Itching, redness & wheel type swelling of injection site after  8 days of inaction
received a late second dose; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 69-year-old female patient who received Herpes zoster (Shingrix) (batch number z4427, expiry date 31st January 2031) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 1st September 2018).   On 19th October 2021, the patient received the 2nd dose of Shingrix. On 19th October 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The patient had received a late second dose of Shingrix on the same day of the report, which led to lengthening of vaccination schedule. No further events were reported. The reporter agreed to be contacted for follow-up.
Received 2 doses of Pfizer vaccine and was diagnosed with COVID 19; Received 2 doses of Pfizer vaccine and was diagnosed with COVID 19; This is a spontaneous report received from a contactable consumer, the patient. This 80-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) on 26Jan2021 (at the age of 79-year-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) on 16Feb2021 12:00 (at the age of 80-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history, allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received 2 doses of Pfizer vaccine and was diagnosed with COVID 19 on 16Mar2021. No treatment was received for the adverse events. The patient was tested positive for nasal swab COVID-19 test (post vaccination) on 16Mar2021. The clinical outcome of "received 2 doses of Pfizer vaccine and was diagnosed with COVID 19" was resolving.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow-up.
some lower back pain that traveled down to her feet/ felt like when someone has sciatica pain; slight headache; felt dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt dizzy), BACK PAIN (some lower back pain that traveled down to her feet/ felt like when someone has sciatica pain) and HEADACHE (slight headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced DIZZINESS (felt dizzy) and HEADACHE (slight headache). On 13-Mar-2021, the patient experienced BACK PAIN (some lower back pain that traveled down to her feet/ felt like when someone has sciatica pain). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, DIZZINESS (felt dizzy), BACK PAIN (some lower back pain that traveled down to her feet/ felt like when someone has sciatica pain) and HEADACHE (slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Itchiness slightly below the injection site; Developed an allergic reaction; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Developed an allergic reaction), VACCINATION SITE PRURITUS (Itchiness slightly below the injection site) and MYALGIA (Sore arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     The patient's past medical history included Malaria and Lymph node dissection (lymph nodes were removed due to cancer). Concurrent medical conditions included Cancer, Allergy (Very allergic NOS), Glaucoma, Allergy to antibiotic, Fruit allergy (Allergy to Mango) and Food allergy (Allergy to Chia). Concomitant products included COLECALCIFEROL (VITAMINS D3), VITAMIN C [ASCORBIC ACID], VITAMIN B1 NOS, VITAMIN B6, VITAMIN B12 [VITAMIN B12 NOS], CURCUMIN, FISH OIL, PROBIOTICS NOS, COLLAGEN, CLONAZEPAM (RIVOTRIL), LISINOPRIL and FAMOTIDINE (NOVATAC) for an unknown indication.    On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-May-2021, the patient experienced MYALGIA (Sore arm). On 07-Jun-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness slightly below the injection site). In June 2021, the patient experienced ALLERGY TO VACCINE (Developed an allergic reaction). On 02-Jun-2021, MYALGIA (Sore arm) had resolved. At the time of the report, ALLERGY TO VACCINE (Developed an allergic reaction) and VACCINATION SITE PRURITUS (Itchiness slightly below the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant medications included unspecified eye drops and glaucoma medication. No treatment medication was provided.   This case was linked to MOD-2021-270028 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received contains significant information: Event added: Developed an allergic reaction, medical history updated: Malaria, Allergy to Chia, Mango, Outcome of events updated On 28-Jul-2021: Follow up received contains No New Information
Patient was seating in her chair after getting her vaccine and she passed out while waiting in chair and fell down on floor. She did not remember what happened to her and she was in senses after about 10 seconds. We rush to her form pharmacy to waiting area and by the time we reach to her she wan in senses. Her friend was with her who also got the same shot. I asked about her health and she said she is perfectly fine .  Her communication was to the point, her vision was normal and she had no complaints of injury in her body. Then she rested in chair for little over 15 minutes and then left. I frequently checked her while waiting she she was fine. They left pharmacy after 20 minutes of waiting and she was fine when leaving the pharmacy waiting area.
pt recvd vax 6 hrs later, exp diaphoresis & n; had mult episodes of v;devel weakness;seen in ofc c/o inflammation of legs;in waiting rm, pt became syncopal & orthostatic;extremely pale, sweaty & clammy; questionable petechiae; to er;
Fever as high as 101.6, body aches, severe pain at injection site, convulsions/chills, nausea, cough, migraine
Patient developed rash on hands bilaterally 30 minutes after receiving MenQuadfi vaccine
This spontaneous report as received from a medical assistant refers to a 17 year old male patient. On 21-FEB-2014 the patient was vaccinated with a fourth dose of GARDASIL (0.5 ml, intramuscular, in the left arm, lot number was not reported). The reporter stated this error occurred when they were converting paper charts to electronic records. Vaccinations dates of the previous vaccinations with GARDASIL were not reported. The reporter stated that the patient did not experience any adverse effect due to the extra dose of GARDASIL. This is one of several reports from the same reporter. Additional information is not expected because the reported doesn't want to be contacted.
Catch up vaccination of Hep B administered 4/11/16 that expired 4/1/16.
pt recvd vax & exp low grade fever for 24 to 48 hrs p/vax; w/in 24 hrs fever was 100 & leg was red & inflammed & could not walk on it; 5DEC pt down w/t102 by noon time; lt ear infect; stopped breathing, pale, limp, not responsive, lips blu
I awoke with terrible stabbing pain in my upper back. This is unlike any pain I had before. It was a shearing pain that woke me out of a sound sleep. I also had chills and was shaking uncontrollably.
When the plunger was pushed the liquid ran down the side of her arm; When the plunger was pushed the liquid ran down the side of her arm; when the plunger was pushed the liquid ran down the side of her arm; A spontaneous report was received from a nurse who was a 71-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and when the plunger was pushed the liquid ran down the side of her arm.   The patient's medical history, as provided by the reporter, included an allergy to Macrobid, breast cancer, hypothyroidism, and hypertension. Concomitant medications included Metoprolol Succinate, Bupropion Hydrochloride, Fluoxetine Hydrochloride, Liothyronine Sodium, and Valaciclovir Hydrochloride.  On 07 Jan 2021 at 10:45 a.m., the patient received their first of two planned doses of mRNA-1273 (Lot Number: 011J20A) in her right deltoid for prophylaxis of COVID-19 infection.   On 07 Jan 2021, the patient noticed that when the vaccine plunger was pushed, liquid ran down the side of her arm. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, when the plunger was pushed the liquid ran down the side of her arm, was considered resolved on 07 Jan 2021.; Reporter's Comments: This report refers to a case of incorrect dose administered, exposure via skin contact, and syringe issue for mRNA-1273, lot # 011J20A.  There were no reported AEs associated with this case of incorrect dose administered, exposure via skin contact, and syringe issue.
Erythema, fatigue, nausea. The rash is not general body rash but rather restricted to her right thigh/knee area but looks bad.
It?s been over three weeks since my first injection and I still have a large lump and the injection site.
Pt. developed erythema, induration & itching. The area on her arm was 12x15 cm. She was treated with ice application & Atarax.
pt recv vax 6/7/99 & devel raised red area @ site which over 48hr devel a bluish center w/red halo, warm & tender size 6x5cm;
no adverse event---administration error only. Patient needed to be 16 to receive vaccine, but was only 15 yrs old
Red rash. Dr orders Benadryl 100mg times 1 dose PO;Benadryl 100mg PO at bedtime times 5 days.
I checked my blood sugar levels and they seems to be extremely high; I do have a little soreness but it only seems to affect me when I raise my arm; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on 10Feb2021 15:30 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced in morning I checked blood sugar levels and they seems to be extremely high, I do have a little soreness but it only seems to affect me when i raise my arm. It is not painful probably the right word, but it is sore. Patient stated, wondered if that was a reaction to the shot to increase in blood sugar level patient arms seems fine. Blood sugar level checked it twice and just trying to figure out if that is normal reaction or not. Patient wanted to know only question really is, is this a normal reaction to have the blood sugar number higher. The patient underwent lab tests and procedures which included blood glucose was extremely high. The outcome of event was unknown.
Had a seizure; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program. Forwarded as an Adverse Event by the Escalation team on 23Aug2021.  A patient of unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date in 2021 as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included that patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date in 2021 as dose 1, single for COVID-19 immunization. On an unspecified date in 2021, patient had a seizure shortly after getting the second dose of your vaccine. To date, doctors have found nothing, and all tests continue to result in negative and normal results. Patient was healthy up until got this crap put into body. Just more big pharma making money hand over fist. Are gullible and stupid sorry, but for one, would not put another Pfizer vaccine in body. The outcome of event seizure was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Patient in observation after her 1st Pfizer injection when she reported feeling her heart beating fast and complaining
About a 9 to 10 days after the shot, I experienced heart palpitations, shortness of breath, pains on the left side of my chest and on my left side, pains under my left shoulder blade, dizziness, nauseous, loss of appetite, headaches/migraines, extreme fatigue, abnormal heart beats ( arrhythmia), diarrhea, sore dry throat, excessive bruising without cause, dull pains in joins (behind knees, hips, shoulders), high blood pressure ( I have NEVER had high blood pressure before).
Started with burning and pain in eyes. Then sudden loss of vision, blurry and double vision. She was a healthy girl with excellent vision. Abdominal pains that come and go. Lack of appetite and loss of weight. Severe headaches and light sensitivity. Eyes have been abnormally dilated since sudden onset of vision loss. Muscle weakness and listless. A week has passed and the only improvement is that her double vision is gone. But vision is still blurry and other symptoms still remain as well.    Doctors are not very helpful and have not taken appropriate action to help her. We have see the pediatrician, eye doctor, emergency room, neurologist and our family doctor. My daughter has not been given any treatment. We have only been told to give her Motrin and Tylenol. She has vision loss and pains yet we have been brushed off and treated as if nothing is wrong with her. Her abdomen has not even been checked. We had to demand bloodwork to be done. The Emergency room failed to recognize other possible exams and treatments.  I've never been so disgusted in my life.
Tinnitus in my right year that continues to this day. Also, rash on my upper right arm that lasted several days. Rash was hot, raised and blotchy.
Patient's mother brought patient in to receive a COVID-19 Pfizer vaccine on 08/28/2021.  The patient?s mother filled out a consent form on behalf of the patient and listed the date of birth as 07/22/2009 and signed and consented on the official Public Health Pfizer-BioNTech consent form.  The nurse verified the name and date of birth with the patient and the patient?s mother.  Public Health guidelines were followed, and the parent received the up-to-date Pfizer-BioNTech EUA and the vaccine was administered.  In the patient?s 15-minute wait there were no adverse reactions. Three weeks later, on 09/18/2021 the mother once again filled out a consent form and stated her child's birthday was 07/22/2009. Upon entering the vaccine into the Immunization Information System it was discovered that the patient's true DOB was 07/22/2010  and therefore this was an unauthorized vaccination.  The date of birth was then confirmed and verified in the Database.  The Public Health Department Chief Medical Director was notified.  In addition, the patient's mother and pediatrician were notified per protocol.
This patient had a temperature of 100.8, chills, sore throat, non-productive cough, "ache all over", headache, laryngitis for 5 days. Treatment: antibiotic (Zithromax). No "head cold".
This spontaneous report was received from a physician and refers to his 5 year old daughter. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported. On 18-MAR-2016, the patient was vaccinated with a dose of ZOSTAVAX, intramuscularly, at an unspecified location in the thigh (dose, dosage number, lot # and expiration date were not reported), instead of being vaccinated with VARIVAX (Merck). It was also reported that she received a couple of other unspecified vaccines on the same day. The reporter stated that, on 18-MAR-2016, the patient developed a local reaction which was quite significant and aggressive for 4 or 5 days. The reporter stated that the area of injection had become the "size of a softball with a red wheal area that was warm to touch and tender" (injection site swelling) (injection site erythema) (injection site warmth) (injection site pain). The area itched quite a bit, but the patient did not break out with any type of rash (injection site pruritus). Subsequently, it was reported that, on 19-MAR-2016, she developed a fever of 101.5 F (pyrexia) and was administered ibuprofen for treatment. By 20-MAR-2016, her temperature had decreased back to normal. Following this, the reporter had contacted the patient's physician and sent a picture of the affected injection site area. The physician instructed the reporter to give the patient BENADRYL in order to alleviate the redness and swelling. It was reported that the patient received two doses of BENADRYL on 21-MAR-2016 and within 24 hours, the injection site reaction had drastically improved. Furthermore, the reporter stated that the patient had also experienced a headache (headache) for 5 days and at the time of reporting, she was still complaining of "aching in her feet and ankles" (arthralgia) (pain in extremity) and itching at the injection site. It was also reported that no laboratory diagnostic studies were performed. The patient recovered from pyrexia on 20-MAR-2016 and, at the time of reporting, was recovering from the events of injection site erythema, injection site swelling, injection site warmth and injection site pain. Additionally, she recovered from the headache on an unspecified date in March 2016. However, at the time of reporting, the patient had still not recovered from the pain in extremity, arthralgia and injection site pruritus. The reporter, also, provided no causal relationship between the events and vaccination with ZOSTAVAX. Additional information has been requested.
Flu; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: Dec2021, for COVID-19 immunization; Bnt162b2 (Dose 2), administration date: Dec2021, for COVID-19 immunization. The following information was reported: INFLUENZA (non-serious), outcome "unknown", described as "Flu". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Lower back and leg pain, low grade (99.5) fever, headache  beginning ~7 hours post vaccine and lasting ~12 hours  Injection site pain?ongoing, 48 hours later
Patient had generalized anxiety disorder. Onsite EMS was called vitals  BP 140/84 HR 99  100% O2.  Patient refused evaluation and care. Released to go home against medical advise.            Patient had an allergic reaction. Onsite EMS was called vitals BP 142/100 HR 92 98% O2. Patient
I had severe muscle cramping in my legs last night; This spontaneous case was reported by a patient and describes the occurrence of MUSCLE SPASMS (I had severe muscle cramping in my legs last night) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (I had severe muscle cramping in my legs last night). At the time of the report, MUSCLE SPASMS (I had severe muscle cramping in my legs last night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Case number PHHY2012US013523 is an initial literature report received on 14 Feb 2012. Authors published the adverse events following administration of H1N1 vaccine to pregnant women that were reported to Vaccine Adverse Event Reporting System. This case refers to a neonate born to a pregnant female (see linked case: PHHY2012US013487) on an unspecified date. The mother was vaccinated with pandemic influenza vaccine (manufacturer and batch number: unknown) at an unknown gestational period between 01 Oct 2009 to 28 Feb 2010. The neonate had intraparenchymal hemorrhage. The outcome of the event was not reported. Authors concluded that the pregnant women who were vaccinated with 2009 H1N1 vaccination with inactivated and live vaccines did not show unusual pattern of maternal or fetal outcomes. The most common pregnancy specific adverse event was spontaneous abortion (SAB) and stillbirth, and more than a third of women who experienced SAB had at least one risk factor (advance maternal age). Seventy two percent of women who had stillbirth had at least one risk factor and had a pathological finding in the fetus or placenta, suggesting factor other than vaccination that may be contributed to the fetal demise. This suggested that women with higher risk were overrepresented in VAERS database.
Around noon after getting vaccine, I was getting dizzy spells and a headache. My arm was tender. I went to bed around 7 pm and I woke up around 10 pm. I was dripping in sweat and shivering. My back was sore. It felt like my back was on fire. It felt hot and sore. My arm was still sore. I didn't go to work. I got my kids ready and around 8:00 am I threw up. And throughout the day, until around 3 pm, I was sweating, no fever, I had a headache and I was extremely tired. I wanted to sleep all day. My arm was still sore. After around 3 pm, I felt fine. Pregnancy history - my third pregnancy. I have two children already. Date of Delivery: August 27, 2021. With each pregnancy, I get a little more nauseous and a little more sore.
Nodule at injection site (Right arm). Redness at injection site (Right arm). Warmth at site (Right arm). Fever. Headache.
pain & stiffness in left arm 6:30 am . weakness in legs 7pm . fever of 101.5 11 am also tired